276 related articles for article (PubMed ID: 10722486)
1. Efficacies of imipenem, meropenem, cefepime, and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing beta-lactamase-producing strain of Enterobacter cloacae.
Mimoz O; Leotard S; Jacolot A; Padoin C; Louchahi K; Petitjean O; Nordmann P
Antimicrob Agents Chemother; 2000 Apr; 44(4):885-90. PubMed ID: 10722486
[TBL] [Abstract][Full Text] [Related]
2. Efficacies of cefepime, ceftazidime, and imipenem alone or in combination with amikacin in rats with experimental pneumonia due to ceftazidime-susceptible or -resistant Enterobacter cloacae strains.
Mimoz O; Jacolot A; Leotard S; Hidri N; Samii K; Nordmann P; Petitjean O
Antimicrob Agents Chemother; 1998 Dec; 42(12):3304-8. PubMed ID: 9835534
[TBL] [Abstract][Full Text] [Related]
3. Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae.
Mimoz O; Jacolot A; Padoin C; Tod M; Samii K; Petitjean O
J Antimicrob Chemother; 1998 Mar; 41(3):367-72. PubMed ID: 9578163
[TBL] [Abstract][Full Text] [Related]
4. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
5. Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
Mimoz O; Elhelali N; Léotard S; Jacolot A; Laurent F; Samii K; Petitjean O; Nordmann P
J Antimicrob Chemother; 1999 Jul; 44(1):91-7. PubMed ID: 10459815
[TBL] [Abstract][Full Text] [Related]
6. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
[TBL] [Abstract][Full Text] [Related]
7. Cefepime and amikacin synergy against a cefotaxime-susceptible strain of Enterobacter cloacae in vitro and in vivo.
Mimoz O; Jacolot A; Padoin C; Caillon J; Louchahi K; Tod M; Samii K; Petitjean O
J Antimicrob Chemother; 1997 Mar; 39(3):363-9. PubMed ID: 9096186
[TBL] [Abstract][Full Text] [Related]
8. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli.
Nordmann P; Mariotte S; Naas T; Labia R; Nicolas MH
Antimicrob Agents Chemother; 1993 May; 37(5):939-46. PubMed ID: 8517720
[TBL] [Abstract][Full Text] [Related]
9. Relative importances of outer membrane permeability and group 1 beta-lactamase as determinants of meropenem and imipenem activities against Enterobacter cloacae.
Cornaglia G; Russell K; Satta G; Fontana R
Antimicrob Agents Chemother; 1995 Feb; 39(2):350-5. PubMed ID: 7726496
[TBL] [Abstract][Full Text] [Related]
10. Markedly different rates and resistance profiles exhibited by seven commonly used and newer beta-lactams on the selection of resistant variants of Enterobacter cloacae.
Chan WC; Li RC; Ling JM; Cheng AF; Schentag JJ
J Antimicrob Chemother; 1999 Jan; 43(1):55-60. PubMed ID: 10381101
[TBL] [Abstract][Full Text] [Related]
11. [Detection of plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in a strain of carbapenem-resistant Enterobacter cloacae].
Cai JC; Zhou HW; Chen GX; Zhang R
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):135-8. PubMed ID: 18353225
[TBL] [Abstract][Full Text] [Related]
12. AmpD is required for regulation of expression of NmcA, a carbapenem-hydrolyzing beta-lactamase of Enterobacter cloacae.
Naas T; Massuard S; Garnier F; Nordmann P
Antimicrob Agents Chemother; 2001 Oct; 45(10):2908-15. PubMed ID: 11557489
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program.
Sun HK; Kuti JL; Nicolau DP
Crit Care Med; 2005 Oct; 33(10):2222-7. PubMed ID: 16215374
[TBL] [Abstract][Full Text] [Related]
14. Novel Cassette Assay To Quantify the Outer Membrane Permeability of Five β-Lactams Simultaneously in Carbapenem-Resistant
Kim TH; Tao X; Moya B; Jiao Y; Basso KB; Zhou J; Lang Y; Sutaria DS; Zavascki AP; Barth AL; Reeve SM; Schweizer HP; Deveson Lucas D; Boyce JD; Bonomo RA; Lee RE; Shin BS; Louie A; Drusano GL; Bulitta JB
mBio; 2020 Feb; 11(1):. PubMed ID: 32047131
[TBL] [Abstract][Full Text] [Related]
15. SHV-12 extended spectrum beta-lactamase associated with high-level ceftazidime resistance in Enterobacter cloacae isolated from Thailand.
Tansawai U; Boonkerd N; Polwichai P; Dejsirilert S; Niumsup PR
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):148-54. PubMed ID: 19323047
[TBL] [Abstract][Full Text] [Related]
16. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate.
Barnaud G; Labia R; Raskine L; Sanson-Le Pors MJ; Philippon A; Arlet G
FEMS Microbiol Lett; 2001 Feb; 195(2):185-90. PubMed ID: 11179650
[TBL] [Abstract][Full Text] [Related]
17. [Efficacies of ceftazidime and cefepime in rats with experimental pneumonia caused by extended-spectrum beta-lactamase-producing strain of Klebsiella pneumonia].
Wang WF; Liu YN; She DY
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):390-4. PubMed ID: 17045021
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics-Pharmacodynamics of CB-618 in Combination with Cefepime, Ceftazidime, Ceftolozane, or Meropenem: the Pharmacological Basis for a Stand-Alone β-Lactamase Inhibitor.
Ambrose PG; VanScoy BD; Trang M; McCauley-Miller J; Conde H; Bhavnani SM; Alexander DC; Friedrich LV
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28947474
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Selection of Enterobacter cloacae with Cefepime, Meropenem, and Ceftazidime-Avibactam Generates Diverse Resistance Mechanisms.
Castanheira M; Lindley J; Doyle TB; Davis AP; Sader HS
Int J Antimicrob Agents; 2023 Jan; 61(1):106698. PubMed ID: 36464152
[TBL] [Abstract][Full Text] [Related]
20. Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae.
Rasmussen BA; Bush K; Keeney D; Yang Y; Hare R; O'Gara C; Medeiros AA
Antimicrob Agents Chemother; 1996 Sep; 40(9):2080-6. PubMed ID: 8878585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]